Suphannee Limprathan

Suphannee Limprathan practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Suphannee Limprathan's NPI, 1487205225, was assigned on September 23, 2019. Suphannee Limprathan holds California license NP95011885.

Suphannee Limprathan's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Suphannee Limprathan's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Suphannee Limprathan is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Suphannee Limprathan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Suphannee Limprathan practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Suphannee Limprathan's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Suphannee Limprathan is licensed in California.

CMS counts 81 Medicare patients who saw Suphannee Limprathan in 2026. The largest group is 65 to 74, with 47 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 40% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Suphannee Limprathan's median patient age at 60, with 49% women.

In 2026, Suphannee Limprathan wrote 609 Medicare Part D claims for 127 patients. 67% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Suphannee Limprathan for performance year 2026, reported as part of a group. Suphannee Limprathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Suphannee Limprathan as offering telehealth.

CMS Open Payments shows 15 general payments to Suphannee Limprathan from 9 drug and device companies in 2025. Food and beverage make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $230.